SMaRT-PD: A Clinical Decision Support System for the Management of Parkinson’s Disease
Objective: To optimise the accuracy of a clinical decision support system (CDSS) to support Self-Management, Remote monitoring and Timely review in Parkinson’s Disease (SMaRT-PD). Background:…Speech Processing System for Parkinson’s Disease Using Mixed Reality
Objective: Our initiative aims to develop an integrated AR/MR platform for collecting diagnostic data and monitoring patients with neurodegenerative diseases using digital markers from registered…Transcriptome analysis of proteasome and inflammation in the substantia nigra of Parkinson’s disease patients: the GEO database.
Objective: In this study, we analyzed transcriptome data regarding protein degradation pathways and inflammation sourced from GEO database. Background: Parkinson's disease (PD) is the second…Remote DNA Collection for Parkinson’s Research: Insights from AccessPD
Objective: Established in 2022, the AccessPD registry aims to create a comprehensive database of electronic health records, self-reported outcomes, and genetic data from Parkinson's disease…Expanding the Spectrum of Autosomal Recessive Genes Responsible for Parkinson’s Disease in the Chinese Population
Objective: We aimed to identify novel candidate autosomal recessive (AR) genes combining whole-exome sequencing (WES) and long-read sequencing data (LRS) in autosomal recessive Parkinson’s disease (AR-PD) families and sporadic early-onset…Diagnosing Young-Onset and Familial Parkinson’s Disease Using an Extensive Targeted Panel
Objective: To explore the diagnostic yield of a large PD-targeted panel that contains 85 genes in a Taiwanese cohort of young-onset and familial PD. Background:…Rare Variant Association Analysis in Kazakhstani Parkinson’s Disease Population: Preliminary Results from GP2 CAT-PD Study
Objective: To identify rare genetic variants in genes, previously associated with Parkinson’s disease (PD) within a population consisting of individuals with PD and unaffected controls…Altered levels of interleukin-6 in Parkinson’s disease patients with and without Covid-19
Objective: Comparison of serum IL-6 levels in Parkinson's disease (PD) patients with and without Сovid-19. Background: Scientists say that the infectious agent SARS-CoV-2 increases the…Comparison of Monopolar and Bipolar Sensing of Beta Frequency in Parkinson’s Disease of the Subthalamic Nucleus for Deep Brain Stimulation
Objective: To compare bipolar sensing (BS) with monopolar sensing (MS) of local field potentials (LFP) within the beta band of subthalamic nucleus (STN) in Parkinson’s…Do Proton Pump Inhibitors Increase the Risk of Parkinson’s Disease? A systematic review and meta-analysis
Objective: To provide an updated meta-analysis of the observational studies examining the association between proton pump use and Parkinson’s disease. Background: The exact cause of…
- « Previous Page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- …
- 338
- Next Page »